Mulay James's Form 4 filing
CG Oncology, Inc. (CGON) · filed Jun 16, 2026
- Accession no.
- 0001684531-26-000002
- Filed
- Jun 16, 2026
- Trade date
- Jun 15, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $118.1K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mulay JamesCIK 0001684531 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | Common Stock | MOption exerciseAcquired | +654 | $3.72 | +$2,432.88 | 654 | Direct | |
| Jun 15, 2026 | Common Stock | SSaleDisposed | −654 | $60.12 | −$39,318.48 | 0 | Direct | |
| Jun 15, 2026 | Common Stock | MOption exerciseAcquired | +1,310 | $12.59 | +$16,492.9 | 1,310 | Direct | |
| Jun 15, 2026 | Common Stock | SSaleDisposed | −1,310 | $60.12 | −$78,757.2 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | Common Stock | MOption exerciseDisposed | −654 | $0.00 | $0 | 0 | Direct | |
| Jun 15, 2026 | Common Stock | MOption exerciseDisposed | −1,310 | $0.00 | $0 | 2,620 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.